PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35127852-8	2021	IGFBP-1 and IGFBP-1/IGF-1 ratio positively correlated with N-terminal probrain natriuretic peptide (NT-proBNP) levels (r = 0.255, p = 0.002; r = 0.224, p = 0.007, respectively).	nt-probnp	100-109	insulin like growth factor binding protein 1	Homo sapiens	0-7	
35127852-8	2021	IGFBP-1 and IGFBP-1/IGF-1 ratio positively correlated with N-terminal probrain natriuretic peptide (NT-proBNP) levels (r = 0.255, p = 0.002; r = 0.224, p = 0.007, respectively).	nt-probnp	100-109	insulin like growth factor binding protein 1	Homo sapiens	12-19	
35127852-11	2021	In HF, IGFBP-1 and IGFBP-1/IGF-1 ratio positively correlated with NT-proBNP levels.	nt-probnp	66-75	insulin like growth factor binding protein 1	Homo sapiens	19-26	
32597241-10	2021	IGFBP-1 correlated specifically to N-terminal prohormone of brain natriuretic peptide (NT-proBNP) (r = 0.44, p < .002), mean right atrial pressure (r = 0.41, p < .004), venous oxygen saturation (r = -0.43, p < .003), cardiac index (r = -0.32, p < .03) and 6-minute walking distance (r = -0.29, p < .05).	nt-probnp	87-96	insulin like growth factor binding protein 1	Homo sapiens	0-7	
32597241-14	2021	However, IGFBP-1 changes, between baseline and follow-up, correlated to changes in NT-proBNP (r = 0.48, p < .006).	nt-probnp	83-92	insulin like growth factor binding protein 1	Homo sapiens	9-16	
32597241-15	2021	Conclusion: Plasma IGFBP-1 levels at PAH diagnosis show moderate association to NT-proBNP and hemodynamics as well as with ESC/ERS and REVEAL risk scores.	nt-probnp	80-89	insulin like growth factor binding protein 1	Homo sapiens	19-26